Last reviewed · How we verify

Rotavirus Vaccine, Live, Pentavalent

Sanofi Pasteur, a Sanofi Company · FDA-approved active Biologic

Rotavirus Vaccine, Live, Pentavalent is a Live attenuated vaccine Biologic drug developed by Sanofi Pasteur, a Sanofi Company. It is currently FDA-approved for Prevention of rotavirus gastroenteritis in infants and young children. Also known as: RotaTeq®.

A live attenuated pentavalent rotavirus vaccine that stimulates immune responses against the five most common rotavirus serotypes to prevent rotavirus gastroenteritis.

A live attenuated pentavalent rotavirus vaccine that stimulates immune responses against the five most common rotavirus serotypes to prevent rotavirus gastroenteritis. Used for Prevention of rotavirus gastroenteritis in infants and young children.

At a glance

Generic nameRotavirus Vaccine, Live, Pentavalent
Also known asRotaTeq®
SponsorSanofi Pasteur, a Sanofi Company
Drug classLive attenuated vaccine
ModalityBiologic
Therapeutic areaImmunology / Infectious Disease
PhaseFDA-approved

Mechanism of action

The vaccine contains live, weakened strains of rotavirus (serotypes G1, G2, G3, G4, and P1A) that replicate in the intestinal tract and induce both humoral and mucosal immune responses. This generates protective antibodies and cellular immunity against rotavirus infection, reducing the incidence and severity of rotavirus-caused diarrhea in infants and young children.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Rotavirus Vaccine, Live, Pentavalent

What is Rotavirus Vaccine, Live, Pentavalent?

Rotavirus Vaccine, Live, Pentavalent is a Live attenuated vaccine drug developed by Sanofi Pasteur, a Sanofi Company, indicated for Prevention of rotavirus gastroenteritis in infants and young children.

How does Rotavirus Vaccine, Live, Pentavalent work?

A live attenuated pentavalent rotavirus vaccine that stimulates immune responses against the five most common rotavirus serotypes to prevent rotavirus gastroenteritis.

What is Rotavirus Vaccine, Live, Pentavalent used for?

Rotavirus Vaccine, Live, Pentavalent is indicated for Prevention of rotavirus gastroenteritis in infants and young children.

Who makes Rotavirus Vaccine, Live, Pentavalent?

Rotavirus Vaccine, Live, Pentavalent is developed and marketed by Sanofi Pasteur, a Sanofi Company (see full Sanofi Pasteur, a Sanofi Company pipeline at /company/sanofi).

Is Rotavirus Vaccine, Live, Pentavalent also known as anything else?

Rotavirus Vaccine, Live, Pentavalent is also known as RotaTeq®.

What drug class is Rotavirus Vaccine, Live, Pentavalent in?

Rotavirus Vaccine, Live, Pentavalent belongs to the Live attenuated vaccine class. See all Live attenuated vaccine drugs at /class/live-attenuated-vaccine.

What development phase is Rotavirus Vaccine, Live, Pentavalent in?

Rotavirus Vaccine, Live, Pentavalent is FDA-approved (marketed).

What are the side effects of Rotavirus Vaccine, Live, Pentavalent?

Common side effects of Rotavirus Vaccine, Live, Pentavalent include Diarrhea, Vomiting, Fever, Irritability, Intussusception.

Related